English | Español

Astrazeneca Pharmaceuticals Lp
Mark Iandolo | Nov 22, 2017

AstraZeneca's benralizumab receives positive opinion from European Medicines Agency's CHMP
Mark Iandolo | Nov 22, 2017

AstraZeneca, MedImmune deliver 28 presentations at AHA Scientific Sessions
Nicholas Gueguen | Aug 1, 2017

MedImmune, Sanofi Pasteur to create and market respiratory tract illness prevention drug
Nicholas Gueguen | Jul 23, 2017

FDA approves AstraZeneca's Tagrisso for treating certain forms of lung cancer
Robert Hadley | Jul 5, 2017

AstraZeneca’s Faslodex to treat breast cancer a step closer to approval in Europe
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients
Ruth de Jauregui | Jun 7, 2017

AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting

Trending
+ Pharmaceuticals
Patient Daily | Aug 8, 2025

PhRMA Chief Public Affairs Officer on 340B abuse: ‘Big, tax-exempt hospitals in urban areas are using a loophole to qualify as “rural”’
Patient Daily | Aug 7, 2025

Dallas Breathe Free Sinus & Allergy Centers earns 4.8-star rating from 670 Google reviews
Patient Daily | Aug 4, 2025

Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
Patient Daily | Aug 1, 2025

Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’